Anzeige
Mehr »
Mittwoch, 29.04.2026 - Börsentäglich über 12.000 News
250 Tage bis zum Pentagon-Magnetverbot: Wie ein 46-Mio.-CAD-Small-Cap profitieren könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von The Motley Fool

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DiMicrosoft vs. Amazon: Which AI Stock Is the Better Buy?
Di3 Green Energy Stocks for Investors Playing the Long Game in 2026
DiFailure to Launch: United Launch Alliance Is in Trouble. Who Wins From Its Loss?
DiIntel Just Shocked Everyone, but Is the Stock Still a Buy?
DiIf This ETF Is Not in Your Portfolio, It Might Be Time to Ask Why
DiShould You Rush to Get in on the SpaceX IPO? History Offers a Strikingly Clear Answer.
DiShould You Buy SoundHound AI Stock Before May 7? The Answer Might Surprise You.
Di2 Energy Dividend Stocks Paying You to Wait While Oil Prices Stay Elevated
DiPrediction: Palantir Stock Is Going to Plunge on May 5
DiPrediction: Amazon Stock Will Soar After April 29
DiReformulating the "Magnificent Seven": 2 Stocks I'd Swap Out for Ultimate Upside
DiCan You Invest in Jersey Mike's Pre-IPO?
DiBuy 1 Artificial Intelligence (AI) Stock With More Upside Than Palantir, According to Wall Street Analysts
DiSigns Point to Warren Buffett's Successor, Greg Abel, Dumping the Oracle of Omaha's Former No. 2 Holding at Berkshire Hathaway
DiShould You Buy CoreWeave Stock Before May 7?
Di3 AI Stocks Shaping the Future of Technology to Buy Now, According to Wall Street
DiCan You Invest in SpaceX Pre-IPO?
DiWhy This Week Could Be Huge For AI Stocks
DiThis Artificial Intelligence (AI) Stock Just Grew Revenue 34% and Landed Its Biggest Contract Ever. Is It a Buy for 2026?
DiThese 3 Stocks Are Incredible Long-Term Bargains
DiPrediction: Intel Stock's Best Days Are Behind It -- and Here's the Chip Stock to Buy Instead
DiTempted To Buy the SpaceX IPO? This Is The Smarter Stock To Buy
DiTeva Pharmaceutical's Turnaround Is Working. Here's When to Buy the Stock.
DiThis Stock Has a Mouth-Watering 6% Dividend Yield -- and It's a Buy
DiIs This Deal a Game Changer for Novo Nordisk?